Literature DB >> 30404098

Giant Prolactinomas.

Ilan Shimon1,2.   

Abstract

Prolactin-secreting adenomas (prolactinomas) are the most common secreting adenomas of the pituitary. Microprolactinomas (diameter <10 mm) are frequently diagnosed in women, whereas macroprolactinomas (maximum diameter ≥10 mm) are generally seen in men. Most macroprolactinomas measure between 10 and 40 mm. Giant prolactinomas, measuring >40 mm, are rare, accounting for only 1-5% of all prolactinomas. Although generally benign, giant prolactinomas are aggressive and invasive, extending into the suprasellar region and also involving the cavernous sinuses. The optic chiasm is frequently involved, which leads to visual damage, and patients occasionally suffer from ophthalmoplegia. Long-term (usually lifetime) therapy with high-dose dopamine agonists (cabergoline or bromocriptine), together with pituitary surgery in some cases and radiotherapy if required, can achieve biochemical remission, tumor control, and clinical improvement in most patients.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Cabergoline; Dopamine agonist; Giant prolactinoma; Prolactin; Prolactinoma

Mesh:

Year:  2018        PMID: 30404098     DOI: 10.1159/000495184

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  14 in total

Review 1.  Surgery for prolactinomas: a better choice?

Authors:  Jürgen Honegger; Isabella Nasi-Kordhishti; Nuran Aboutaha; Sabrina Giese
Journal:  Pituitary       Date:  2020-02       Impact factor: 4.107

Review 2.  Aggressive prolactinoma (Review).

Authors:  Ana Valea; Florica Sandru; Aida Petca; Mihai Cristian Dumitrascu; Mara Carsote; Razvan-Cosmin Petca; Adina Ghemigian
Journal:  Exp Ther Med       Date:  2021-11-24       Impact factor: 2.447

3.  Giant prolactinoma in children and adolescents: a single-center experience and systematic review.

Authors:  Sandeep Kumar; Vijaya Sarathi; Anurag Ranjan Lila; Manjeetkaur Sehemby; Saba Samad Memon; Manjiri Karlekar; Shilpa Sankhe; Virendra A Patil; Nalini Shah; Tushar Bandgar
Journal:  Pituitary       Date:  2022-07-18       Impact factor: 3.599

4.  Ruptured aneurysm-induced pituitary apoplexy: illustrative case.

Authors:  Michiharu Yoshida; Takeshi Hiu; Shiro Baba; Minoru Morikawa; Nobutaka Horie; Kenta Ujifuku; Koichi Yoshida; Yuki Matsunaga; Daisuke Niino; Ang Xie; Tsuyoshi Izumo; Takeo Anda; Takayuki Matsuo
Journal:  J Neurosurg Case Lessons       Date:  2021-06-28

Review 5.  High-risk pituitary adenomas and strategies for predicting response to treatment.

Authors:  George Kontogeorgos; Eleni Thodou; Robert Y Osamura; Ricardo V Lloyd
Journal:  Hormones (Athens)       Date:  2022-01-21       Impact factor: 2.885

6.  A Silent Corticotroph Pituitary Carcinoma: Lessons From an Exceptional Case Report.

Authors:  Pablo Remón-Ruiz; Eva Venegas-Moreno; Elena Dios-Fuentes; Juan Manuel Canelo Moreno; Ignacio Fernandez Peña; Miriam Alonso Garcia; Miguel Angel Japón-Rodriguez; Florinda Roldán; Elena Fajardo; Ariel Kaen; Eugenio Cardenas Ruiz-Valdepeñas; David Cano; Alfonso Soto-Moreno
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-21       Impact factor: 5.555

7.  Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors.

Authors:  Renato Cozzi; Maria Rosaria Ambrosio; Roberto Attanasio; Claudia Battista; Alessandro Bozzao; Marco Caputo; Enrica Ciccarelli; Laura De Marinis; Ernesto De Menis; Marco Faustini Fustini; Franco Grimaldi; Andrea Lania; Giovanni Lasio; Francesco Logoluso; Marco Losa; Pietro Maffei; Davide Milani; Maurizio Poggi; Michele Zini; Laurence Katznelson; Anton Luger; Catalina Poiana
Journal:  Eur J Endocrinol       Date:  2022-02-03       Impact factor: 6.664

8.  Comparison of the effects of medical and surgical treatments in giant prolactinoma: a single-center experience.

Authors:  Soner Cander; Ozen Oz Gul; Eda Eylemer; Elif Gullulu Boz; Elif Gunes; Bahattin Hakyemez; Selcuk Yilmazlar; Canan Ersoy
Journal:  Hormones (Athens)       Date:  2021-07-08       Impact factor: 2.885

9.  Commentary: "Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery".

Authors:  Lukas Andereggen; Emanuel Christ
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-14       Impact factor: 5.555

10.  Giant Prolactinoma Presenting With Facial Nerve Palsy and Hemiparesis.

Authors:  Aleksandra Sliwinska; Fatima Jalil; Lori De La Portilla; Michael Baldwin; Joseph Lorenzo; Ketan R Bulsara; Faryal S Mirza
Journal:  J Endocr Soc       Date:  2021-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.